A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache

Glostrup Hospital, Glostrup Municipality

Centre Hospitalier Regional de la Citadelle, Liège

401 Army General Hospital of Athens, Athens

Eginition Hospital of Athens, Athens

APHM Hôpital de la Timone, Marseille

Thomas Jefferson University, Philadelphia

Terveystalo Pulssi, Turku

Istituto Neurologico Carlo Besta, Milan

Fondazione Istituto Neurologico Nationale C. Mondino, Pavia

Clinical Trials of South Carolina, Charleston

Atlanta Center of Medical Research, Atlanta

University of South Florida, Tampa

Suomen Terveystalo, Jyväskylä

CHU St Etienne Hopital Nord, Saint-Etienne

Praxis Dr. Philipp Stude, Bochum

Universitaetsklinikum Essen, Essen

Hospital Clínico Universitario de Valencia, Valencia

Michigan Head, Pain and Neurological Institute, Ann Arbor

Azienda Ospedaliera Universitaria Careggi, Florence

CHRU de Lille - Hôpital Roger Salengro, Lille

Migräne- und Kopfschmerzklinik GmbH & Co. KG, Königstein im Taunus

Hopital Lariboisière, Paris

Colorado Neurological Institute, Englewood

Klinikum der Universität München, München

Mayo Clinic Hospital, Phoenix

California Medical Clinic for Headache, Santa Monica

Stanford University Hospital, Palo Alto

New England Institute for Clinical Research, Stamford

Northwest Clinical Research Center, Bellevue

Universitair Ziekenhuis Gent, Ghent

Stroyan Research, Toronto

Centre de Traitement Neurologique, Montreal

Hôpital de Cimiez, Nice

Universitätsklinikum Jena, Jena

Boerhaave Medisch Centrum, Amsterdam

Canisius-Wilhelmina Ziekenhuis, Nijmegen

Hospital Universitari Vall d'Hebron, Barcelona

Hull Royal Infirmary, Hull

Walton Centre for Neurology and Neurosurgery, Liverpool

Royal Stoke University Hospital, Stoke-on-Trent